Kala Bio Files ATM Offering Of Up To $250M In Common Stock
-SEC Filing
Read original at benzingaStocks · News reference
Kala Bio Q2 EPS $(21.32) Up From $(85.64) YoY, Sales $0.00, Same YoY
Kala Bio (NASDAQ:KALA) reported quarterly losses of $(21.32) per share. This is a 75.11 percent increase over losses of $(85.64) per share from the same period last year. The company reported $0.00 in sales this
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Aug 19, 2026, 9:07 PM
- Checked
- Aug 19, 2026, 9:07 PM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading